Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

ClinicalTrials.gov ID: NCT02288273

Public ClinicalTrials.gov record NCT02288273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Double-blind, Parallel-group Study to Evaluate the Effect of Bydureon Compared with Placebo on 24-hour Glucose Control in Metformin-treated Patients with Type 2 Diabetes.

Study identification

NCT ID
NCT02288273
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AstraZeneca
Industry
Enrollment
239 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2014 (Type not available)
Primary completion
Aug 2015 (Actual)
Completion
Aug 2015 (Actual)
Last update posted
Jan 27, 2017

2014 – 2015

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Research Site Anaheim California — —
Research Site Chino California — —
Research Site Los Angeles California — —
Research Site North Hollywood California — —
Research Site Santa Ana California — —
Research Site Spring Valley California — —
Research Site Tustin California — —
Research Site Walnut Creek California — —
Research Site Hollywood Florida — —
Research Site Miami Florida — —
Research Site Port Orange Florida — —
Research Site Marietta Georgia — —
Research Site Chicago Illinois — —
Research Site Edina Minnesota — —
Research Site St Louis Missouri — —
Research Site Butte Montana — —
Research Site Las Vegas Nevada — —
Research Site Franklin Ohio — —
Research Site Marion Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Mt. Pleasant South Carolina — —
Research Site Rapid City South Dakota — —
Research Site Corpus Christi Texas — —
Research Site Houston Texas — —
Research Site Katy Texas — —
Research Site Salt Lake City Utah — —
Research Site Burke Virginia — —
Research Site Manassas Virginia — —
Research Site Olympia Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02288273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02288273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →